Literature DB >> 2828656

Identification of the E5 open reading frame of human papillomavirus type 16.

C L Halbert1, D A Galloway.   

Abstract

Sequencing of the E5 open reading frame (ORF) of human papillomavirus type 16 revealed an additional nucleotide, a thymidine residue, at position 3903 compared with the original sequence (Seedorf et al., Virology 145:181-185, 1985). The additional T had two effects; first, in reading frame 2, in which the original E5 ORF was predicted, the additional T changed the reading frame downstream of position 3903 to create an ORF, which we designated E5, that terminated at position 4018 and potentially encoded a 52-amino-acid polypeptide. Secondly, in reading frame 3, a new ORF was created (positions 3807 to 4097), which we propose is the authentic papillomavirus type 16 E5 ORF. It contained a methionine residue and encoded an additional 82 amino acids. Both ORFs have been cloned into bacterial expression vectors (pATH), and the fusion proteins have been used to generate polyclonal antibodies in rabbits.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828656      PMCID: PMC253670          DOI: 10.1128/JVI.62.3.1071-1075.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Cellular transformation by human papillomavirus DNA in vitro.

Authors:  S L Watts; W C Phelps; R S Ostrow; K R Zachow; A J Faras
Journal:  Science       Date:  1984-08-10       Impact factor: 47.728

2.  Comparative analysis of the human type 1a and bovine type 1 papillomavirus genomes.

Authors:  O Danos; L W Engel; E Y Chen; M Yaniv; P M Howley
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

3.  Bovine papillomavirus contains multiple transforming genes.

Authors:  Y C Yang; H Okayama; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells.

Authors:  E Schwarz; U K Freese; L Gissmann; W Mayer; B Roggenbuck; A Stremlau; H zur Hausen
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

5.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

6.  Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers.

Authors:  L Gissmann; L Wolnik; H Ikenberg; U Koldovsky; H G Schnürch; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

7.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.

Authors:  M Dürst; L Gissmann; H Ikenberg; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines.

Authors:  E J Androphy; N L Hubbert; J T Schiller; D R Lowy
Journal:  EMBO J       Date:  1987-04       Impact factor: 11.598

9.  DNA sequence and genome organization of genital human papillomavirus type 6b.

Authors:  E Schwarz; M Dürst; C Demankowski; O Lattermann; R Zech; E Wolfsperger; S Suhai; H zur Hausen
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer.

Authors:  M Boshart; L Gissmann; H Ikenberg; A Kleinheinz; W Scheurlen; H zur Hausen
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

View more
  20 in total

1.  Characterization of human papillomavirus type 57b: transforming activity and comparative sequence analysis as probes for biological determinants associated with high-risk oncogenic viruses.

Authors:  J M Trujillo; T C Wu; P Mounts
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

2.  Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope.

Authors:  S A Jenison; X P Yu; J M Valentine; D A Galloway
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization.

Authors:  C M Wheeler; T Yamada; A Hildesheim; S A Jenison
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

4.  E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis.

Authors:  Benyue Zhang; Dan F Spandau; Ann Roman
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  The regulation mechanism of c-jun and junB by human papillomavirus type 16 E5 oncoprotein.

Authors:  S L Chen; C H Huang; T C Tsai; K Y Lu; Y P Tsao
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Mutational analysis of bovine papillomavirus type 1 E5 peptide domains involved in induction of cellular DNA synthesis.

Authors:  J A Rawls; P M Loewenstein; M Green
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

7.  Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.

Authors:  R Kirnbauer; J Taub; H Greenstone; R Roden; M Dürst; L Gissmann; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

8.  Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice.

Authors:  Yi-Fang Chen; Chih-Wei Lin; Yeou-Ping Tsao; Show-Li Chen
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16.

Authors:  C Leptak; S Ramon y Cajal; R Kulke; B H Horwitz; D J Riese; G P Dotto; D DiMaio
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  Genotyping human papillomavirus type 16 isolates from persistently infected promiscuous individuals and cervical neoplasia patients.

Authors:  A van Belkum; L Juffermans; L Schrauwen; G van Doornum; M Burger; W Quint
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.